Monosomy 13 is associated with the transition of monoclonal gammopathy of undetermined significance to multiple myeloma

Blood

Volumn 94, Issue 8, 1999, Pages 2583-2589

  Avet Loiseau, Hervé ^a   Li, Jian Yong ^b   Morineau, Nadine ^b   Facon, Thierry ^b   Brigaudeau, Christophe ^b   Harousseau, Jean Luc ^b   Grosbois, Bernard ^b   Bataille, Régis ^b  

^a INSTITUT DE BIOLOGIE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANAMNESIS; ARTICLE; CELL SUBPOPULATION; CHROMOSOME 14Q; CHROMOSOME ABERRATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MONOCLONAL IMMUNOGLOBULINEMIA; MONOSOMY; MULTIPLE MYELOMA; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL;

EID: 0032857034     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.8.2583.420a05_2583_2589     Document Type: Article

References (29)

1. Dewald GW, Kyle RA, Hicks GA, Greipp PR: The clinical significance of cytogenetics studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood 66:380, 1985
2. Gould J, Alexanian R, Goodacre A, Pathak S, Hecht B, Barlogie B: Plasma cell karyotype in multiple myeloma. Blood 71:453, 1988
3. Weh HJ, Gutensohn K, Selbach J, Kruse R, Wacker-Backhaus G, Seeger D, Fiedler W, Fett W, Hossfeld DK: Karyotype in multiple myeloma and plasma cell leukemia. Eur J Cancer 29A:1269, 1993
4. Laï JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490, 1995
5. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetics findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41, 1995
6. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Sole F, Cuesta B, Gullon A: Cytogenetic analysis of 280 patients with multiple myeloma and related disorder: Primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84, 1997
7. Drach J, Schuster J, Nowotny H, Angerler J, Rosenthal F, Fiegl M, Rothermundt C, Gsur A, Jaeger U, Heinz R, Lechner K, Ludwig H, Huber H: Multiple myeloma: High incidence of chromosomal aneuploidy as detected by interphase fluorescence in situ hybridization. Cancer Res 55:3854, 1995
8. Flactif M, Zandecki M, Laï JL, Bernardi F, Obein V, Bauters F, Facon T: Interphase fluorescence in situ hybridization (FISH) as a powerful tool for the detection of aneuploidy in multiple myeloma. Leukemia 9:2109, 1995
9. Perez-Simon JA, Garcia-Sanz R, Tabernero MD, Almeida J, Gonzalez M, Fernandez-Calvo J, Moro MJ, Hernandez JM, San Miguel JF, Orfao A: frognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomes. Blood 91:3366, 1998
10. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, Kashima K: Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of 1p in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283, 1994
11. Seong C, Delasalle K, Hayes K, Weber D, Dimopoulos M, Swantkowski J, Huh Y, Classman A, Champlin R, Alexanian R: Prognostic value of cytogenetics in multiple myeloma. Br J Haematol 101:189, 1998
12. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931, 1996
13. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526, 1997
14. Avet-Loiseau H, Li JY, Facon T, Brigaudeau C, Morineau N, Maloisel F, Rapp M-J, Talmant P, Trimoreau F, Jaccard A, Harousseau J-L, Bataille R: High incidence of translocations t(11;14)(q13;q32) and t(4;14)(p16;q32) in patients with plasma cell malignancies. Cancer Res 58:5640, 1998
15. Avet-Loiseau H, Brigaudeau C, Talmant P, Laï JL, Daviet A, Li JY, Praloran V, Rapp MJ, Harousseau JL, Facon T, Bataille R: High incidence of cryptic translocations involving the Ig heavy chain gene in multiple myeloma, as shown by fluorescence in situ hybridization. Genes Chromosomes Cancer 24:9, 1999
16. Kyle RA: "Benign" monoclonal gammopathy: After 20 to 35 years of follow-up. Mayo Clin Proc 68:26, 1993
17. Kyle RA, Beard CM, O'Fallon M, Kurland LT: Incidence of multiple myeloma in Olmsted County, Minnesota: 1978 through 1990, with a review of the trend since 1945. J Clin Oncol 12:1577, 1994
18. Drach J, Angerler J, Schuster J, Rothermundt C, Thalhammer R, Haas OA, Jager U, Fiegl M, Geissler K, Ludwig H, Huber H: Interphase fluorescence in situ hybridization identifies chromosomal abnormalities in plasma cells from patients with monoclonal gammopathy of undetermined significance. Blood 86:3915, 1995
19. Zandecki M, Obein V, Bernardi F, Soenen V, Flactif M, Lai JL, Francois M, Facon T: Monoclonal gammopathy of undetermined significance: Chromosome changes are a common finding within bone marrow plasma cells. Br J Haematol 90:693, 1995
20. Zandecki M, Lai JL, Genevieve F, Bernardi F, Volle-Remy H, Blanchet O, Francois M, Cosson A, Bauters F, Facon T: Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition. Blood 90:3682, 1997
21. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1996
22. Richelda R, Ronchetti D, Baldini L, Cro L, Viggiano L, Marzella R, Rocchi M, Otsuki T, Lombardi L, Maiolo AT, Neri A: A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. Blood 90:4062, 1997
23. Kyle RA, Greipp PR: Smoldering multiple myeloma. N Engl J Med 302:1347, 1980
24. Durie BGM, Salmon SE: Multiple myeloma, macroglobulinaemia and monoclonal gammopathies, in Hoffbrand AV, Brain MC, Hirsh J (eds): Recent Advances in Haematology. Edinburgh, UK, Churchill Livingstone, 1977, p 243
25. Portier M, Rajzbaum G, Zhang XG, Attal M, Rusalen C, Wijdenes J, Mannoni P, Maraninchi D, Piechaczyc M, Bataille R, Klein B: In vivo interleukin 6 expression in the tumoral environment in multiple myeloma. Eur J Immunol 21:1759, 1991
26. Avet-Loiseau H, Garand R, Gaillard F, Daviet A, Mellerin MP, Robillard N, Bouyge I, Arcot S, Batzer M, Talmant P, Harousseau JL, Milpied N, Bataille R: Detection of the t(11;14) using interphase molecular cytogenetics in mantle cell lymphoma and atypical chronic lymphocytic leukemia. Genes Chromosomes Cancer 23:175, 1998
27. H gene mutational pattern indicate different tumor cell status in human myeloma and monoclonal gammopathy of undetermined significance. Blood 87:746, 1996
28. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR: Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250, 1995
29. Smadja NV, Fruchart C, Isnard F, Louvet C, Dutel JL, Cheron N, Grange MJ, Monconduit M, Bastard C: Chromosomal analysis in multiple myeloma: Cytogenetic evidence of two different diseases. Leukemia 12:960, 1998